Eledon Pharmaceuticals to Participate in LifeSci Partners Immunology & Inflammation Symposium

Rhea-AI Summary

Eledon Pharmaceuticals, a clinical stage biopharmaceutical company specializing in treatments for transplant and autoimmune conditions, announced its participation in a fireside chat at the LifeSci Partners Immunology & Inflammation Symposium on May 10, 2022, at 2:00 p.m. ET. Interested individuals can register for the webcast here. A replay will later be available on the company's website.

IRVINE, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, today announced that management will participate in a fireside chat at the LifeSci Partners Immunology & Inflammation Symposium on Tuesday, May 10^th at 2:00 p.m. ET.

To register in advance for the fireside chat webcast, sign up here.

A webcast replay will be accessible following the live session on the Events page of the Investors section on the Company’s website at https://ir.eledon.com/events-and-presentations/events.

About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501)

Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop potential treatments for persons requiring an organ or cell-based transplant, living with autoimmune disease, or living with ALS. The company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, Calif. For more information, please visit the company’s website at www.eledon.com.

Follow Eledon Pharmaceuticals on social media: LinkedIn; Twitter

Investor Contact:

Stephen Jasper
Gilmartin Group
(858) 525-2047
stephen@gilmartinir.com

FAQ

What date is Eledon Pharmaceuticals participating in the LifeSci Partners Symposium?

Eledon Pharmaceuticals will participate in the LifeSci Partners Immunology & Inflammation Symposium on May 10, 2022.

What time does Eledon Pharmaceuticals' fireside chat start?

The fireside chat will start at 2:00 p.m. ET.

How can I register for Eledon Pharmaceuticals' fireside chat?

You can register for the fireside chat webcast by visiting the registration link provided in their press release.

Where can I find the replay of Eledon Pharmaceuticals' fireside chat?

A webcast replay will be accessible on the Events page of Eledon Pharmaceuticals' Investors section on their website.

What is the focus of Eledon Pharmaceuticals' research?

Eledon Pharmaceuticals focuses on innovative treatments for organ and cell transplantation, autoimmune diseases, and neurodegenerative conditions.